Skip to main content

Ani Pharmaceuticals Inc

ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001023024

In the last 90 days, Ani Pharmaceuticals Inc insiders filed 0 open-market purchases and 10 sales; 307 institutions reported holding it in 13F filings for Q2 2026, worth $1.90B in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Ani Pharmaceuticals Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
132
+15 vs. Q3 2021
Shares held
8.97M
+1.69M (+23.2%) vs. Q3 2021
Total value
$413.4M
+$174.5M (+73.1%) vs. Q3 2021
New holders
35
50 more added
Sold out
20
30 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ANIP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 132 institutions
Q1 2021: 106 institutionsQ2 2021: 116 institutionsQ3 2021: 118 institutionsQ4 2021: 132 institutionsQ1 2022: 126 institutionsQ2 2022: 120 institutionsQ3 2022: 126 institutionsQ4 2022: 126 institutionsQ1 2023: 138 institutionsQ2 2023: 172 institutionsQ3 2023: 186 institutionsQ4 2023: 181 institutionsQ1 2024: 200 institutionsQ2 2024: 201 institutionsQ3 2024: 208 institutionsQ4 2024: 206 institutionsQ1 2025: 231 institutionsQ2 2025: 233 institutionsQ3 2025: 269 institutionsQ4 2025: 285 institutionsQ1 2026: 281 institutionsQ2 2026: 307 institutions
Value heldQ4 2021: $413.4M
Q1 2021: $263.5MQ2 2021: $252.7MQ3 2021: $238.8MQ4 2021: $413.4MQ1 2022: $258.8MQ2 2022: $293.4MQ3 2022: $330.3MQ4 2022: $412.4MQ1 2023: $411.7MQ2 2023: $662.5MQ3 2023: $766.4MQ4 2023: $750.8MQ1 2024: $975.2MQ2 2024: $962.3MQ3 2024: $1.12BQ4 2024: $1.07BQ1 2025: $1.34BQ2 2025: $1.29BQ3 2025: $1.87BQ4 2025: $1.67BQ1 2026: $1.80BQ2 2026: $1.90B
Institutions holding ANIP and their total value by quarter
QuarterHoldersValue
Q2 2026307$1.90B
Q1 2026281$1.80B
Q4 2025285$1.67B
Q3 2025269$1.87B
Q2 2025233$1.29B
Q1 2025231$1.34B
Q4 2024206$1.07B
Q3 2024208$1.12B
Q2 2024201$962.3M
Q1 2024200$975.2M
Q4 2023181$750.8M
Q3 2023186$766.4M
Q2 2023172$662.5M
Q1 2023138$411.7M
Q4 2022126$412.4M
Q3 2022126$330.3M
Q2 2022120$293.4M
Q1 2022126$258.8M
Q4 2021132$413.4M
Q3 2021118$238.8M
Q2 2021116$252.7M
Q1 2021106$263.5M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Ani Pharmaceuticals Inc; share changes are against Q3 2021.

Institutions holding ANIP in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Walthausen & Co., LLC61,456$2.83M0.74%+61,456New
LSV Asset Management63,300$2.92M0.01%−25,400−28.6%Reduced
Kingdon Capital Management, L.L.C.65,000$3.00M0.45%+65,000New
Invesco Ltd.69,409$3.20M0.00%−1,812−2.5%Reduced
Marathon Capital Management74,770$3.44M0.81%+575+0.8%Added
Principal Financial Group Inc77,830$3.59M0.00%+11,774+17.8%Added
Emerald Advisers, LLC82,944$3.82M0.14%+82,944New
Two Sigma Advisers, LP86,800$4.00M0.01%+48,800+128.4%Added
Emerald Mutual Fund Advisers Trust89,491$4.12M0.15%+89,491New
Russell Investments Group, Ltd.94,654$4.36M0.01%−18,975−16.7%Reduced
Summit Partners Public Asset Management, LLC96,910$4.47M0.21%+96,910New
Brandywine Global Investment Management, LLC97,094$4.47M0.03%+83,754+627.8%Added
Renaissance Technologies LLC98,502$4.54M0.01%+40,202+69.0%Added
Ranger Investment Management, L.P.110,751$5.10M0.28%+250.0%Added
Two Sigma Investments, LP111,480$5.14M0.01%+86,817+352.0%Added
Northern Trust Corp125,759$5.79M0.00%+7,374+6.2%Added
Parkman Healthcare Partners LLC137,226$6.32M1.43%+51,880+60.8%Added
Bank of New York Mellon Corp141,379$6.51M0.00%+45,477+47.4%Added
Geode Capital Management, LLC203,453$9.38M0.00%+40,416+24.8%Added
Deutsche Bank AG226,640$10.4M0.00%+34,166+17.8%Added
Federated Hermes, Inc.263,777$12.2M0.02%−13,078−4.7%Reduced
Thompson Siegel & Walmsley LLC279,554$12.9M0.18%−170,950−37.9%Reduced
Ameriprise Financial Inc283,077$13.0M0.00%+9,132+3.3%Added
Global Alpha Capital Management Ltd.284,831$13.1M1.27%+220,399+342.1%Added
Tang Capital Management LLC300,000$13.8M2.78%+300,000New
Rubric Capital Management LP307,557$14.2M0.67%+307,557New
First Wilshire Securities Management Inc328,494$15.1M4.72%−5,192−1.6%Reduced
Dimensional Fund Advisors LP389,304$17.9M0.01%+11,088+2.9%Added
State Street Corp437,580$20.2M0.00%+26,560+6.5%Added
William Blair Investment Management, LLC451,444$20.8M0.06%+77,338+20.7%Added
Vanguard Group Inc716,776$33.0M0.00%+71,962+11.2%Added
BlackRock Inc.1,686,613$77.7M0.00%+174,984+11.6%Added
Assenagon Asset Management S.A.0$00.00%−33,058−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−26,345−100.0%Sold out
Squarepoint Ops LLC0$00.00%−14,882−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−14,548−100.0%Sold out
HRT Financial LP0$00.00%−8,064−100.0%Sold out
Winton Group Ltd0$00.00%−7,788−100.0%Sold out
Millennium Management LLC0$00.00%−7,076−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−6,345−100.0%Sold out
Aigen Investment Management, LP0$00.00%−6,266−100.0%Sold out
DekaBank Deutsche Girozentrale0$00.00%−3,450−100.0%Sold out
Meeder Asset Management Inc0$00.00%−1,392−100.0%Sold out
Penserra Capital Management LLC0$00.00%−290−100.0%Sold out
Simplex Trading, LLC0$00.00%−174−100.0%Sold out
Daiwa Securities Group Inc.0$00.00%−27−100.0%Sold out
Meridian Wealth Partners, LLC0$00.00%−44−100.0%Sold out
Gradient Investments LLC0$00.00%−1−100.0%Sold out
MCF Advisors LLC0$00.00%−1−100.0%Sold out
Sargent Bickham Lagudis LLC0$00.00%−13−100.0%Sold out
Jacobi Capital Management LLC0$00.00%−5−100.0%Sold out
Kowal Investment Group, LLC0$00.00%−1−100.0%Sold out
Berman Capital Advisors, LLC––––Not filed